From French roots to international reach

Horus Pharma builds on its long-standing presence in France, where it has established itself as the country’s second-largest independent ophthalmic pharmaceutical company and a leading player in Europe.

This privileged position forms the basis of an ambitious internationalisation strategy that has been yielding strong results since 2010. With €116 million in revenue in 2025, including over 15% generated internationally, we have enjoyed double-digit growth for 22 years, demonstrating the strength of our business model.